Recent Comments

Comment RSS

Antidepressant News and Research RSS Feed - Antidepressant News and Research

Antidepressants are medicines that treat depression. Your doctor can prescribe them for you. They can improve your mood, sleep, appetite and concentration. It may take several weeks for them to help. There are several types of antidepressants. You and your doctor may have to try several before finding what works best for you.

FDA approves sNDA for pediatric autism drug ABILIFY

20. November 2009 23:40
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods. [More]

Antidepressant drug is effective in treating women with low libido

17. November 2009 01:49
The drug flibanserin, which was originally created as an antidepressant, is effective in treating women with low libido, pooled results from three separate clinical trials have found. [More]

Posted in: Women's Health News | Pharmaceutical News

Tags: , , , ,

Potential benefits of Labopharm's novel trazodone formulation published

11. November 2009 04:19
Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery. [More]

Competitive intelligence report on Portugal's pharmaceuticals and healthcare industry

7. November 2009 01:51
Research and Markets has announced the addition of the "Portugal Pharmaceuticals and Healthcare Report Q4 2009" report to their offering. [More]

Posted in: Pharmaceutical News

Tags: ,

Rush University Medical Center opens TMS Clinic to offer non-drug treatment for depression

6. November 2009 01:07
Rush University Medical Center has opened the Transcranial Magnetic Stimulation (TMS) Clinic to offer patients suffering from major depression a safe, effective, non-drug treatment. TMS therapy is the first FDA-approved, non-invasive antidepressant device-based treatment clinically proven for treatment of depression. [More]

Posted in: Healthcare News

Tags: , , , , , ,

Referenced-EEG outperforms STAR*D treatment in depression care

4. November 2009 03:02
CNS Response, Inc. reported the results of a landmark study presented by Charles DeBattista, D.M.H, M.D., at the U.S. Psychiatric and Mental Health Congress. [More]

Posted in: Medical Research News | Medical Condition News

Tags: , , , , ,

Monash University physiologist honored with Life Scientist of the Year award

30. October 2009 06:09
A Monash University physiologist, whose research into weight management, obesity and diabetes has led to significant medical breakthroughs and drug design, has been awarded one of the nation's top research honours. [More]

Posted in: Medical Science News

Tags: , , , , , , , ,

New clinical uses for old hypertension drug leads to several patents

28. October 2009 06:11
University of South Florida neuroscientist R. Douglas Shytle's discovery of successful new clinical uses for mecamylamine, a drug once used to treat hypertension, has led to several issued patents on mecamylamine and related compounds. Earlier this month, Shytle, associate professor and research scientist at the USF Center of Excellence for Aging and Brain Repair and the USF Silver Child Development Center, received the university's 2009 "Excellence in Innovation" award. [More]

Posted in: Medical Patent News | Pharmaceutical News

Tags: , , , , ,

Antidepressant market to decline: Datamonitor

28. October 2009 06:06
Research and Markets (http://www.researchandmarkets.com/research/881581/commercial_insight) has announced the addition of the "Commercial Insight: Antidepressants - Novel Mechanism Offers Hope in Depressed Market" report to their offering. [More]

Posted in: Pharmaceutical News

Tags: , , , , , ,

Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression

28. October 2009 01:10
Prozac works wonders for some depressed people, but not for others. In some cases, patients derive little benefit and at worst, it can lead to bizarre hallucinations and fits of rage. Researchers and doctors remain puzzled as to what causes the wide range of reaction to Prozac and similar antidepressants. [More]

Omega-3 fatty acid supplements do not improve levels of depression in heart disease patients

26. October 2009 01:27
Contrary to the findings of some studies, new research indicates that augmenting antidepressant therapy with an omega-3 fatty acid supplement does not result in improvement in levels of depression in patients with coronary heart disease, according to a study in the October 21 issue of JAMA. [More]

Antidepressants are not effective for many people

24. October 2009 04:11
More than half the people who take antidepressants for depression never get relief. [More]

Antidepressant prescriptions are on the rise

23. October 2009 02:48
A dramatic rise in antidepressant prescriptions issued by GPs has been caused by a year on year increase in the number of people taking antidepressant drugs on a long-term basis, according to researchers from the University of Southampton. [More]

Posted in: Pharmaceutical News

Tags: , , ,

Targacept presents data from Phase 2b clinical trial of TC-5214

20. October 2009 07:59
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide. [More]

Study explores the efficacy of antidepressant drugs for patients with severe depression and medical disorder

20. October 2009 05:19
This study demonstrates that over 6 weeks of treatment, patients with melancholic depression and medical comorbidity (MC) (specifically cardiovascular or endocrinological MC) had poorer treatment response and a worse functional outcome as opposed to their counterparts without MC. Interestingly, these effects were not related to various antidepressant treatment regimens. [More]

Posted in: Medical Condition News

Tags: , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.